EMV Capital Investor
VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors
Technology:
Cell_Therapies, DeepTech, SpaceTech
Industry:
Longevity Industry 2022
Headquarters:
London, England, United Kingdom
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Private
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Late Stage Venture, Seed, Venture
Number Of Exits:
2
Acquisitions Number:
2
Investors Number:
23
Estimated Revenue:
$1M to $10M
Register and Claim Ownership